18th Aug 2016 07:22
LONDON (Alliance News) - Health technology developer Akers Biosciences said Thursday the results for a study of its BreathScan OxiChek, a disposable breath test to determine levels of oxidative stress in the body, were positive.
Akers said the test results were "highly successful", with a correlation between OxiChek and the standard reference laboratory blood testing method of 99.5%.
The firm also said the study demonstrated a reproducibility of 100%, meaning the test results from the same lung simulator had zero variation after multiple repeats.
"We are very excited about these particular study results for OxiChek. Not only do they demonstrate the effectiveness of our test for oxidative stress, but the comparison to the standard reference laboratory test, blood vs breath, is remarkable," said Raymond Akers, co-founder and chief scientific director of Akers.
Shares in Akers were untraded early Thursday, having last traded at 245.00 pence.
By Lucy Heming; [email protected]
Copyright 2016 Alliance News Limited. All Rights Reserved.